CRP and metabolic syndrome: Accordingly, it is not surprising that statin therapy improved the clinical outcome of patients with acute coronary syndromes, as this drug not only prevented dyslipidemia (decreased LDL levels) but also reduced inflammation (lower CRP levels), as shown by the PROVE IT-TIMI 22 study [54].